A Study Evaluating the Role of Oral Antibiotics in an Aim to Eradicate Carrier State of Carbapenem- Resistant Klebsiella Pneumonia (KPC).

ClinicalTrials.gov Show glossary Search for terms Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.

Related documents

• The Combined Antibiotic Therapy for Carbapenem Resistant Klebsiella Pneumoniae#18667
• Comparative analysis of biofilm formation in carbapenem-resistant and carbapenem-susceptible Klebsiella pneumoniae clinical isolates from a tertiary hospital in Nigeria: Analyse comparative de la formation de biofilm chez des isolats cliniques de Klebsiella pneumoniae résistants et sensibles aux carbapénèmes provenant d'un hôpital universitaire du Nigéria#1149019
• Comparison of Bloodstream Infections With Carbapenem Hetero-resistant vs Carbapenem Resistant Klebsiella Pneumoniae#143609
• Epidemiologia molecular, resistência aos antimicrobianos e perfil de virulência de isolados clínicos de Klebsiella pneumoniae resistentes aos carbapenêmicos#646738
• The dual threat of hypervirulent and multidrug-resistant Klebsiella pneumoniae: pathogenesis and prospects for intervention.#351644